Month: February 2026

Singular Genomics Launches G4X™ in the U.S., Delivering Industry-Leading Throughput for In Situ Multiomics, Targets Translational and Clinical Applications

SAN DIEGO, Feb. 18, 2026 /PRNewswire/ -- Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, today...

TRNR Signs Definitive Agreement to Acquire Ergatta, Increasing 2026 Pro Forma Revenue Guidance by 50% to More than $30m

Ergatta's 2026 Revenue is expected to exceed $10 million with approximately 30% EBITDA marginPerformance-linked transaction valuation ensures attractive acquisition multiple...

Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup

Previously announced partnership with Tollo Health subsidiary TolloCare adding telehealth service offering to drive Wellgistics Pharmacy prescription drug dispending of...

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics license...

error: Content is protected !!